Doctor's Guide -- MONTREAL -- October 27, 2010 -- Bucindolol is associated with a reduction in all- cause mortality in patients with advanced systolic heart failure (HF) and systolic blood pressure (SBP) >120 mm Hg, according to a study presented here at the 2010 Canadian Cardiovascular Congress (CCC).
